Tag Archives: diabetes

City Council health chair announces citywide diabetes plan

Diabetes News

[ad_1]

City Council Committee on Health chair Lynn Schulman, a Queens Democrat, announced the Council will be proposing a citywide diabetes reduction plan this year.

“It’s something that the city really hasn’t focused on,” Schulman said. “We need to go into communities with culturally competent education materials.”

The councilmember said the plan will be based on the 90-90-90 strategy developed by the United Nations to tackle the AIDS epidemic. Schulman added she has been in conversation with city Health Comissioner Dr. Ashwin Vasan about her proposal.

Schulman also discussed the City Council’s health goals in 2023 and her views on how the city should take on unlicensed cannabis shops.

[ad_2]

Source link

Study suggests COVID-19 can cause diabetes

Diabetes News
Study: New-Onset Diabetes and COVID-19: Evidence from a Global Clinical Registry. Image Credit: ADragan / Shutterstock

[ad_1]

The authors of a new study under review at Nature Portfolio and currently posted to the Research Square preprint* server showed the clinical possibility that the coronavirus disease 2019 (COVID-19) heightens the risk of developing diabetes mellitus (DM), supporting diabetes screening in those infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 

Study: New-Onset Diabetes and COVID-19: Evidence from a Global Clinical Registry. Image Credit: ADragan / ShutterstockStudy: New-Onset Diabetes and COVID-19: Evidence from a Global Clinical Registry. Image Credit: ADragan / Shutterstock

Background

An increasing body of evidence suggests that COVID-19 is associated with new diabetes diagnoses. However, it is unclear whether COVID-19 detects pre-existing diabetes or induces new-onset diabetes.

Although previous research reported high blood-sugar levels and metabolic consequences resulting from pre-existing diabetes following COVID-19 hospitalization, studies correlating the disease to new-onset DM are scarce.

COVID-19 has been shown to exacerbate pre-existing diabetes. This likely occurs because COVID-19 is associated with low-grade inflammation, which may initiate or worsen insulin resistance. In addition, numerous studies have also demonstrated that SARS-CoV-2 can infest and multiply within insulin-producing pancreatic beta-cells, thus impairing insulin synthesis and secretion. 

However, whether SARS-CoV-2 can cause clinically meaningful changes in glucose metabolism remains unclear. Nevertheless, it may be possible to find an answer by characterizing the clinical symptoms of COVID-19-related diabetes and by determining the period between the onset of hyperglycemia and that of the infection.

It is imperative to establish a causal relationship between COVID-19 and diabetes since both diseases are prevalent throughout the world. Furthermore, establishing a causal relationship will have significant implications for diagnosis, management, public health, and scientific research. Despite this, it remains unclear whether the association between COVID-19 and diabetes results from indirect health consequences of the former, such as – a higher rate of detection of pre-existing diseases, or whether the causative virus (SARS-CoV-2) directly precipitates hyperglycemia. 

Owing to the higher rate of pre-existing disease detection in the COVID era, newly diagnosed diabetes may be explained both during and after an episode of infectious exposure.

The study

This study investigated the possibility that COVID-19 may trigger new-onset diabetes and its associated symptoms by examining average blood-glucose levels at the time of diabetes presentation against a global clinical registry.

A global COVID-19-related diabetes (CoviDIAB) registry was established to determine whether COVID-19 can acutely induce diabetes and its clinical symptoms. The CoviDIAB registry collects information regarding “newly diagnosed diabetes” and “severe metabolic complications associated with pre-existing diabetes” resulting from COVID-19. 

Individuals with a fasting blood glucose of 126 mg/dL or above or non-fasting blood glucose of 200 mg/dL or above, with no prior diabetes history, and those who had never been on glucose-lowering medications, and with their glycated hemoglobin (HbA1c) levels below the diabetic range (< 6.5%) at presentation were categorized as new-onset diabetes. Here, the researchers examined cases of newly diagnosed diabetes that occurred within four weeks of COVID-19 confirmation. In addition, the HbA1c data were evaluated at the time of diabetes detection to rule out pre-existing hyperglycemia and to confirm the association with SARS-CoV-2 infection.

The findings

Data on 537 eligible newly diagnosed diabetes cases was entered from 61 hospitals in 25 countries between 2020-2022. COVID-19 patients with newly diagnosed diabetes at presentation had HbA1c levels above the diagnostic range, suggesting pre-existing hyperglycemia.

In cases with new-onset hyperglycemia after the SARS-CoV-2 infection, individuals displayed glycemic levels above the diagnostic thresholds, although their HbA1c levels remained within the non-diabetic range. The results showed that 22% of newly diagnosed patients with documented HbA1c levels had recently acquired diabetes.

The most common diabetes subtype among adults was type 2 DM (59%), and the “not yet known” subtype (41%). Two newly diagnosed cases of type 1 DM were recorded among children. After COVID-19 resolution, hyperglycemia persisted in 39 of 89 patients (45%) with newly diagnosed diabetes.

For 28 of these individuals, follow-up data beyond three months was collected, demonstrating that five of them were in remission from diabetes, while 23 (82%) remained diabetic. 

The findings suggested that COVID-19 causes clinically significant changes in glucose metabolism. Although this study does not prove that SARS-CoV-2 causes diabetes, it strongly suggests that the virus may impose a diabetogenic aftermath. 

Further, type 2 DM was the predominant subtype among COVID-19 participants with newly diagnosed diabetes. Thus, type 2 DM likely accounts for most newly diagnosed diabetes cases associated with the post-acute phase of the SARS-CoV-2 infection.

This study confirms this phenomenon across diverse geographical locations and ethnicities by incorporating clinical observations from 25 countries. 

Numerous areas for improvement have been identified in this study, including inherent heterogeneity in clinical practice and the judgment of contributing physicians. 

Conclusion

The results of this study suggest that COVID-19 likely has a diabetogenic effect. Thus, individuals exposed to SARS-CoV-2 infection must be screened for diabetes. Further research is necessary to confirm the mechanisms through which the virus interferes with glucose metabolism.

*Important notice

Research Square publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

[ad_2]

Source link

Are people with diabetes more likely to have osteoporosis, bone fractures?

Diabetes News
bone health

[ad_1]

The woman sitting across the table was distressed. She was 60 years old and had diabetes for 20 years. “Two months ago, I developed a bout of coughing, followed by a sharp back pain. The doctor asked for an X Ray and told me that I had fractured my spine! Nothing hit me, I did not fall. It was just a bad coughing spell. How did I break my vertebra?” The pain was severe for a few weeks but gradually settled and she was then allowed to move around with a brace. The woman had osteoporosis, a condition characterised by porous, fragile bones, which break with minimal or no trauma. Usually, weak bones do not result in pain unless they break, and a fracture is often the first clinical symptom.

What is osteoporosis?

Our skeleton provides a frame for our body and protection for the organs within, much like the metal beams and girders that support buildings. Like metal, bones also suffer wear and tear. Unlike metal, however, bones are living tissues and have a remarkable capacity to regenerate and heal. Sites of minor damage are constantly replaced by new, healthy bones. When the capacity of the body to form new bone is unable to keep up with bone loss, there is progressive weakening, resulting in osteoporosis.

During childhood and adolescence, our skeleton grows rapidly. Enabled by vitamin D, the skeleton builds its calcium stores, particularly during puberty. Boys have bigger bones than girls, and accumulate more minerals over a longer period of time. From the age of 30, we begin to lose bone gradually, a process that is accelerated at menopause in women. If left unchecked, this loss gradually weakens the bones, making them brittle and resulting in fractures. Typically, fractures due to osteoporosis occur at the hip, spine, shoulder or wrist and can have a life-changing impact.

Why are diabetics at greater risk of bone fractures?

People with diabetes have a greater risk of breaking their bones. In those with childhood onset, insulin-dependent type 1 diabetes, this risk is increased by two to four-fold. In those with type 2 diabetes, the risk of fracture is 30-50 per cent higher as compared to those without diabetes. We know that diabetes can result in several chronic complications, involving the heart, kidney, eyes and nerves. Fragility fractures can be regarded as a consequence of diabetes too.

Typically, it requires about 10 years (minimum five years) of diabetes to impact fracture risk. Poorly-controlled diabetes with complications confers a greater risk of fracture. Importantly, people with diabetes fracture at a higher bone density than those without diabetes. The T score is a number shown on the DXA bone density report. Typically, fracture risk is thought to increase if the bone density shows a T score of below -2.5, whereas in diabetes this figure is -2. This means that people with diabetes may require intervention earlier, maybe at a T score of -2 rather than -2.5. If they get a fracture, people with diabetes take longer to recover and have poorer outcomes, particularly after hip fracture.

Why are people with diabetes more prone to osteoporosis?

First, people with uncontrolled, long-standing diabetes have poor quality bones, which fracture easily. Second, they have lower muscle mass, which indirectly impacts their bone strength, and also makes them more prone to falling and breaking a bone. Third, older people with diabetes often have associated visual issues or nerve-related issues, which again put them at greater risk of falls and fractures.

How can people with diabetes reduce their risk of fractures?

1) Testing : People with diabetes should get their bone density checked at the age of 50 if they have had diabetes for more than 10 years. For those over 60, it makes sense to have your bone density checked anyway. A T score of below -2 requires attention. Your doctor will decide if you need medication or not. However, routinely checking BMD in younger people – below the age of 50 – is NOT recommended, even if they have diabetes.

2) Control your sugars: Good control of diabetes will protect your bones along with other organs.

3) Calcium: An adequate calcium intake is a must for our bones and dairy products are the main source of calcium. If you have milk allergy, lactose intolerance, vegan habits, or just don’t like milk, you may require supplements, to reach a daily intake of 800-1000 mg.

4) Vitamin D: This plays a crucial role in bone health, and urban Indians are commonly vitamin D-deficient. Increasing sunlight exposure can be a challenge because of the heat in summer and pollution in winter. Please make sure that you use vitamin D fortified milk products and take supplements as directed (1000-2000 IU/day).

5) Dietary protein: Proteins are important for our bones and critical for our muscle mass. Indian diets are often low in protein. Next time you visit the nutritionist/educator, don’t just discuss sweets. Find out ways to enhance your protein intake, to achieve at least 0.8gm/ kg of body weight daily.

5) Exercise: All kinds of exercise help in strengthening our muscles and bones, but weight-bearing exercises (exercising in erect posture) and resistance-training are the most effective.

6) Giving up smoking and controlling alcohol intake help keep our bones healthy.

7) Medication: If your doctor decides you need medication for your bones, even if you do not have any symptoms, please comply. It is similar to treating high BP, cholesterol or sugar, all of which produce no symptoms but can insidiously lead to long-term complications. Modern medication can reduce your fracture risk by half.

If you follow these principles, you can save your bones and reduce your fracture risk considerably.



[ad_2]

Source link

Patient-supporter training improved patient confidence in managing diabetes

Diabetes News
Patient-supporter training improved patient confidence in managing diabetes

[ad_1]

1. In this randomized control trial, providing positive support technique training to patient-supporter dyads was associated with greater patient confidence in managing diabetes.

2. However, increased patient supporter engagement did not lead to significant changes in physiological outcomes.

Evidence Rating Level: 1 (Excellent)

Diabetes is a highly prevalent health condition; however, more than 75% of adults with diabetes in the United States do not meet targets blood pressure, glycemic, or lipid control. Although support from a patient’s family and friends may help facilitate diabetic management, interventions which provided diabetes information to family supporters have not been shown to improve patient outcomes. However, the effectiveness of specific training in positive support techniques has not been tested.

This randomized control trial was conducted at two different United States Veterans Health primary care sites. Patients included in this study were aged 30 to 70 years with type 2 diabetes and hemoglobin A1c (HbA1c) greater than 8%, or systolic blood pressure (SBP) higher than 150mmHg. Patients with a life-limiting illness, serious mental illness, active substance use disorder, or those living in a nursing home were excluded. Each patient had an adult supporter. 239 patient-supporter dyads were randomized 1:1 to intervention or standard care and followed for 12 to 15 months. The intervention group received health coaching sessions focused on positive support techniques, while standard of care included general diabetes education materials. The primary outcome was change in patient confidence in managing diabetes, as measured by the Patient Activation Measure-13 (PAM-13) survey and diabetes-specific cardiac event risk score measured by the UK Prospective Diabetes Study (UKPDS). Secondary outcomes included changes in HbA1c, SBP, and diabetes self-management behavior.

Results demonstrated that dyads in the intervention group had greater improvement in PAM-13 score compared to the control group. However, there were no significant differences in 5-year cardiac event risk score or other physiological outcomes between groups. This study was limited by the generalizability given the demographic of patients within the Veterans Health system. Nonetheless, these results suggest that increasing patient supporters’ engagement in care of adults with diabetes is feasible and can improve key patient behavioral outcomes.

Click to read the study in JAMA Network Open 

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

[ad_2]

Source link

‘Cold wave increases hospitalization, death among diabetes patients’

Diabetes News

[ad_1]


A research team at Ajou University School of Medicine has found that the cold wave during the winter season increases the number of hospitalizations and death among diabetes patients.


An Ajou University School of Medicine research team, led by professor Kim Kyoung-nam of preventive medicine, has found that cold weather increases the hospitalization rate and death of diabetes patients.
An Ajou University School of Medicine research team, led by professor Kim Kyoung-nam of preventive medicine, has found that cold weather increases the hospitalization rate and death of diabetes patients.


The team, led by Professor Kim Kyoung-nam of the Department of Preventive Medicine and Public Health, analyzed the hospitalization and death data among diabetes patients that occurred during the three weeks following the onset of a cold wave. They used two kinds of data — insurance claim data from the National Health Insurance Service and deaths from Statistics Korea.


Professor Kim’s team used a Quasi-Poisson regressions model for time-series data analysis to estimate the association between hospitalizations and deaths due to cold and diabetes by region across the country, and then calculated a national estimate through meta-analysis.


The team defined a cold wave as cases where the average temperature was below the bottom 5 percent for more than two days for five months from November 2021 to March 2022 by region.


As a result, hospitalization and death increased by 1.45 and 2.02 times, respectively, over the three weeks after the cold wave occurred, compared to the non-cold wave period, among diabetes patients. 


The team also confirmed that the stronger the cold wave and the longer the duration, the higher the hospitalization and mortality rate among diabetes patients.


Although further studies are required, the research team stressed that it believes that diabetic patients are more vulnerable to cold because peripheral vasoconstriction is not sufficient when exposed to cold, and their ability to regulate body temperature is reduced.


“While there is a lot of social interest in heat waves due to climate change, we estimate that the health impact from cold waves or low temperatures is greater in mid-latitude regions including Seoul, Shanghai, and New York,” Professor Kim said. “Considering that the number of elderly and diabetics who are particularly sensitive to cold or low temperatures is increasing worldwide, continuous attention and preparation for cold or low weathers are necessary.”


The team hopes that this study will help diabetic patients cope with cold waves or low temperatures that will become more frequent and stronger in the future due to climate change and help shape efficient public health policies, Kim added.


The research, titled Associations between cold spells and hospital admission and mortality due to diabetes: A nationwide multi-region time-series study in Korea,” was published in Science of The Total Environment in September.

[ad_2]

Source link

Diabetes Diet: How To Make Oats Khichdi To Manage Blood Sugar Levels

Diabetes News

[ad_1]

Khichdi is the ultimate comfort food for all Indians. Whether we are exhausted after a long day at work, have an upset stomach, or simply crave something light and wholesome, khichdi has been a saviour for us on many such days. This one-pot dish is not only super easy to make but it is brimming with various health benefits too. The combination of rice, lentils and ghee provides you with carbohydrates and protein that help you keep full for a longer period of time. Not only this but khichdi is also considered to be suitable for people who are suffering from diabetes as it has a low glycaemic index. Considering this, here we bring you a delicious oats khichdi recipe that is ideal for a wholesome lunch meal. 

Also read: Diabetes Diet Tips: 5 Herbs And Spices That May Help Manage Blood Sugar

Oats, the main ingredient in this recipe, has high water and fibre content and may help in managing blood sugar levels. This oats khichdi makes for a nutritious meal and will keep you full for a longer period of time. To make this khichdi, all you need to do is cook oats, moong dal, tomatoes and onions in a pressure cooker along with flavourful masalas. Garnish with fresh coriander leaves and serve hot with yogurt. Take a look at the recipe below:

nq07nduo

Oats Khichdi Recipe: How To Make Oats Khichdi

To begin with the recipe, first, heat oil in a pressure cooker. Add cumin seeds and allow them to crackle. Add chopped onion, and cook till translucent. Now, add ginger and green chillies, and cook for a few more seconds. Add turmeric powder and red chilli powder, followed by tomatoes. Let them cook until tender.

Next, add all the vegetables and rinsed moong dal along with oats. Saut&#233; for a few seconds. Add water and adjust the salt. Pressure cook for around 8-10 minutes. Once the pressure settles down, open the lid, serve hot and enjoy! 

For the complete recipe of oats khichdi, click here.

For more khichdi recipes, click here.

Try this simple recipe to manage blood sugar levels at home and share your experience in the comments section below.

Featured Video Of The Day

Gajar Matar Khichdi Recipe | How To Make Gajar Matar Khichdi

[ad_2]

Source link

Innovative treatment prevents development of diabetes

Diabetes News

[ad_1]

Newswise — Researchers from the Liston lab, at the Babraham Institute, have recently published a preventative therapeutic for diabetes in mice. The team has been able to prevent diabetes in mice by manipulating signalling pathways in pancreatic cells to prevent stress-induced cell death. The treatment targets a pathway common to both major types of diabetes and therefore could have huge therapeutic potential once translated into a clinical treatment.

Dr Kailsah Singh, former research fellow in the Liston lab, described their findings: “Our results show that MANF could prevent the beta cell damage by preventing the inflammation in islets, which is a hallmark of type 1 diabetes.”

For over 35 years there have been failed attempts to prevent type 1 diabetes development. Previous approaches have sought to target the autoimmune nature of the disease, but Dr Adrian Liston, senior Group Leader in the Immunology research programme, wanted to investigate if there was more causing the deterioration in later stages than just the immune response.

The Liston lab sought to understand the role of cell death in the development of diabetes and therefore approached this problem by identifying the pathways that decide whether stressed insulin-producing cells of the pancreas live or die, and therefore determine the development of disease.

Their hope was to find a way to stop this stress-related death, preventing the decline into diabetes without the need to focus solely on the immune system. First, the researchers had to know which pathways would influence the decision of life or death for the beta cell. In previous research, they were able to identify Manf as a protective protein against stress induced cell death, and Glis3 which sets the level of Manf in the cells. While type 1 and 2 diabetes in patients usually have different causes and different genetics, the GLIS3-MANF pathway is a common feature for both conditions and therefore an attractive target for treatments.

In order to manipulate the Manf pathway, the researchers developed a gene delivery system based on a modified virus known as an AAV gene delivery system. The AAV targets beta cells, and allows these cells to make more of the pro-survival protein Manf, tipping the life-or-death decision in favour of continued survival. To test their treatment, the researchers treated mice susceptible to spontaneous development of autoimmune diabetes. Treating pre-diabetic mice resulted in a lower rate of diabetes development from 58% to 18%. This research in mice is a key first step in the development of treatments for human patients.

“A key advantage of targeting this particular pathway is the high likelihood that it works in both type 1 and type 2 diabetes”, explains Dr Adrian Liston. “In type 2 diabetes, while the initial problem is insulin-insensitivity in the liver, most of the severe complications arise in patients where the beta cells of the pancreas have been chronically stressed by the need to make more and more insulin. By treating early type 2 diabetes with this approach, or a similar one, we have the potential to block progression to the major adverse events in late-stage type 2 diabetes.”



[ad_2]

Source link

Lions Clubs grants provide diabetes education for 10,000 school nurses and school personnel

Diabetes News

[ad_1]

Diabetes in youth, both type 1 and type 2, are on the rise, and as studies show this trend is expected to continue. School nurses and school staff, alike, need to be aware of the needs of children with diabetes and be prepared to meet those needs in the education environment. Laws governing this are set by both the federal government and the Code of Virginia.

The Virginia Code requires that training be offered to school staff who care for students with diabetes. It was recognized that not all schools had access to quality training due to geographic location or limited resources. Changes in diabetic treatment/regimens as well as advancing new technologies make it especially important that quality training be made available.

The Virginia Diabetes Council Schools Committee recognized this need and in partnership with like-interest community groups has successfully launched a diabetes e-learning program, “Lions Empowering and Aiding Regional Nurses in Schools,” that is now being used by school divisions throughout the commonwealth. With financial grant support of the Lions Club International and Lions Club 24L, the pilot program began in the 2019–20 school year. Initially, Lions Club enrolled 2,872 participants and as of October 2022 has enrolled 10,000 participants. Nine hundred seventy-five schools are enrolled in the program with 70 school districts participating, as well as private and parochial schools.

People are also reading…

This training program offers current information about diabetes and best practices for the care of students living with diabetes. Salus Education’s “Diabetes Care at School: Bridging the Gap” is a comprehensive program that addresses basic diabetes awareness information for the school staff, as well as in-depth, technical information directed to those who have responsibility of the child during school activities. Continuing education credits for nurses and school personnel are available. The training has been approved by the Virginia Board of Nursing.

Those completing the training include administrators, nurses, bus drivers, cafeteria workers, athletic directors, trainers, coaches, choir and band directors, teachers and office staff. Some schools have adopted the program and include it as part of their orientation. Some make the training mandatory annually.

The program has been successful even beyond the walls of the schools. Participants have said they have a better understanding of their own diabetes, and their family members and are very glad they took the training.

Providing feedback about the program, a user responded, “I think this was very useful and designed with the learner in mind. Because something like diabetes is life threatening the subject can be scary to ask questions or to take the time to really understand. This self-paced computer program lowered my level of stress while allowing me to review and study at a pace comfortable to me.”

VDC partners include Lions Club International, Lions Club District 24L, Virginia Department of Education, Virginia Department of Health and the Virginia Coordinating Body of Diabetes Care.

[ad_2]

Source link

Implementation and delivery of group consultations for young people with diabetes in socioeconomically deprived, ethnically diverse settings | BMC Medicine

Diabetes News

[ad_1]

Developing good value and life-stage oriented care

Introducing group consultations to the diabetes service in the two hospital implementation sites was not straightforward and required careful local experimentation. The appropriate balance between clinical and educational content became a matter of debate, as clinicians were concerned that the typical group consultations format (with standard one-to-one consultations in a group context) would alienate young people who already had low levels of engagement. Instead, they opted for a flexible approach primarily prioritising group interaction on clinically relevant topics, with individual needs addressed indirectly as part of group discussion, rather than replicating one-to-one consultations in the group setting. This also meant that group consultations were not implemented as a substitute to individual clinics but were used purposefully to augment and re-distribute care; when discussing with peers, young people opened up more than they would with clinicians, which resulted in better recognition of their needs and changed the focus of subsequent one-to-one consultations:

‘…they kind of open up. And they may for the first time accept that they’ve not been taking insulin as recommended, or as advised’ (Interview 25 Diabetes consultant)

Experienced diabetes specialist nurses and other members of the implementation team worked closely with a youth worker, whose contribution was instrumental to developing age- and life-stage appropriate, relationship-based group consultations. The youth worker participated actively in sessions, for example delivering ‘icebreakers’ as a group formation activity and contributing to discussions in a way that would level power dynamics, signifying that group consultations focused on young people’s priorities, rather than purely meeting service or cost-efficiency targets. Clinicians valued youth worker support which allowed them to focus on clinical management without juggling multiple roles for which (in many cases) they had never been trained for (such as facilitating groups of young people).

A typical clinic would start with introductions and an ice-breaker, followed by setting ground rules (see Table 2). Depending on the focus of the session, one or more specialists would join, such as diabetes consultants, dietitians, or psychologists. Topics included healthy eating, blood glucose sensors and measurements, exercise, psychology, sex and healthy relationships, hypos and blood tests, diabetic eye screening and annual review information sessions, sex and healthy relationships, and women’s health, among others.

Although clinicians originally intended for young people to be allocated to specific groups meeting repeatedly and developing long-term relationships throughout the programme, in practice, this proved difficult to sustain and group composition became more fluid. Regular attendees particularly welcomed new participants joining the clinics so they could keep learning from different experiences, but groups also benefited from a certain level of consistency to increase connections between members. The youth worker helped in building affinity quickly between young people who had never met each other so they would open up in discussions and feel supported. At the end of each clinic, participants provided feedback and suggestions for improvement in sessions facilitated by the researcher or the youth worker after clinicians had left the room; this was important for ongoing service co-production (alongside dedicated co-design sessions described elsewhere [30]) to continue meeting patient needs and providing young people with a sense of ownership over this new model of care.

Key challenges in the implementation and delivery of group consultations: staff experiences

Delivering group clinics involved working with uncertainty and managing multiple interdependencies across diabetes care pathways. It was not simply a matter of providing individual care to multiple people at the same time. Group consultations required a different degree, mode and depth of preparation, and engagement by clinicians and young people alike. The transition was gradual and required changes in established practices but also surfaced and challenged deeply embedded ways of thinking about patient-centred care provision.

Table 4 provides examples of how complexity underpinned the work required to deliver group consultations, including the challenges staff encountered. There was little scope for standardising the processes followed, especially at the beginning, when diabetes specialist nurses were learning through trial and error. Yet, the need to manage uncertainty continued throughout the programme; each session had to be treated as unique and required comprehensive preparation to meet changing patient needs and address all eventualities (unpredictable participation, parents attending, etc.).

Table 4 Complexity principles underpinning group clinic delivery, including examples from the study and supporting quotes

Self-organisation underpinned efforts to informally co-ordinate between different clinicians providing one-to-one and group care to young people, in terms of selecting participants for group clinics, understanding their needs, inviting the right experts to contribute, and managing interdependencies with other care processes (e.g. diabetes education, individual appointments) (Q3). In-depth clinical and relational knowledge about young people mattered when deciding how to bring them together and facilitate the sessions so they would benefit most; this knowledge needed to be collectively accumulated and negotiated between different clinicians involved and drawn out of medical records. Informal, improvised, and spontaneous interactions between clinicians enabled ongoing co-ordination, largely driven by the efforts of the diabetes specialist nurses, but also other staff involved (e.g. diabetes consultants, research officer). Other practical and logistical challenges ensued, such as securing seminar rooms, adjusting booking processes, and maintaining continuity with the rest of the diabetes service (Q5).

Formal and informal opportunities were needed for reflection and sense-making, and to support learning within and across implementation sites (e.g. implementation and project meetings, co-design, training sessions). Development of adaptive capability became important for clinicians who were delivering a new model of care highly dependent on human relationships. Group clinics involved the dual challenge of delivering good clinical care and education, while facilitating a group of young people. In some cases, it was important for clinicians to engage in emotional work to support groups where conflict and competition emerged and to ensure outcomes remained positive (Q12). Health professionals drew on their skills consulting with young people, but also attended group facilitation training, held regular debriefs between implementation and clinical teams for ongoing adjustment of the model, and derived significant learning from on-the-job trial and error.

Attendance and young people’s motivations

Despite significant effort, mean attendance was relatively low at 32% for site A and 33% for site B—a challenge already familiar to those delivering young adult services. Local teams had to work creatively to make sessions worthwhile regardless of how many young people ended up attending. Despite suggestions that a ‘good’ session should include 6–8 patients, in practice, the ‘right’ number largely depended on the focus and facilitation mode of each session (e.g. more young people could meaningfully participate in a session about exercise compared to psychology). Larger groups did not always guarantee high levels of contribution; there were successful groups with as many as 4 young people who identified with each other and shared openly.

[…] it seemed to be around sort of three, four, five we were getting [to attend], even though you know, we invited more than twenty patients, within a good amount of time. So I think just trying to make sure a lot of people, or as many people as possible would attend, was the biggest challenge. (Interview 29, Diabetes Specialist Nurse)

An average of 4–5 young people attended each group consultation at both sites. Higher attendance rates were recorded when a small group of selected young people were invited for a specific care-focused intervention, such as flash glucose monitoring follow-up (range of 83–100% in three sessions). Variable attendance rates were observed at broader educational and self-management sessions (e.g. psychological health, healthy eating), especially when there was an open invite to all young people recruited at each site (range of 0–60% in 25 sessions). As group clinics continued, attendance was mostly from those who had attended previous sessions, suggesting group consultations appealed to and continued to attract a specific set of young people (5–6 young people attended 5–10 sessions in site A and 3–4 in site B), but the majority only attended a small number of sessions.

Some young people expressed feeling motivated to participate in group consultations, mainly to meet others with diabetes in their age group. However, others were unable to fit group consultations alongside standard, individual diabetes care and other responsibilities (such as family, education, employment, social life). They also expressed feeling ambivalent or in ‘two minds’ about this new service model as they did not know what to expect or did not feel ready to engage with their condition; some overcame initial fears although others chose not to participate at all.

But yeah, it’s like having a group clinic is so much nicer, in order to meet people. But then on the other hand, I think because you don’t really know them, you don’t have that personal connection with them, you don’t really want to voice out everything that you’re going through. Do you get that? I’m a quiet person, like I wouldn’t tell people what I’m going through if I don’t really know them. So I was in like two minds. (Interview 12, Patient 7—never attended)

If I’m being honest, at the beginning, I didn’t want to come. I did, but I didn’t. I just like – oh, when is it going to be, is it going to be really long, I might not like it. But I still came. And I liked it. I was like ‘okay, this isn’t what I was expecting’. I was not expecting it to be so laid back. I don’t know. It was really comfortable, the setting. (Interview 10, Patient 5—regular attendee).

Not all young people had disclosed their diabetes in their communities and they were unsure how to share deeply personal experiences. There was also an underlying resistance to supporting a new consultation mode if this would mean reducing individual appointments for cost efficiency.

Differences between attenders and non-attenders in implementation sites

In Tables 5 and 6, we present baseline characteristics of the 73 young people recruited in the two implementation settings, comparing those who attended one or more group clinics to those who did not attend any group clinics at each site (further comparisons with participants recruited in control sites are available in the detailed project report [30]).

Table 5 Participant baseline characteristics by attendance group and site
Table 6 Baseline clinical characteristics and questionnaire scores by attendance group and site

At site A, comparing participants who did (N = 23) and did not (N = 27) attend any group clinics, there were no significant differences in sex, ethnicity, deprivation, speaking English as a first language, type of diabetes, or use of technology within the last year (Table 5). Those who attended were on average diagnosed at a younger age (11 vs. 16 years) and more likely to have attended group education sessions in the past (39% vs 7%), with borderline statistical significance (p = 0.033 and 0.053 respectively). There were no statistically significant differences in these variables when comparing attenders (n = 14) and non-attenders (n = 9) at site B.

Comparison of attenders and non-attenders at site A showed no statistically significant differences between these groups when comparing baseline clinical characteristics and questionnaire scores (Table 6). In contrast, attenders at site B had better glycaemic control (mean HbA1C 68 vs. 98 mmol/mol, p = 0.023) and had attended 80 vs. 50% of planned appointments within the previous year (p = 0.009).

Young people’s experiences in group clinics

Young people who attended group clinics (especially repeat attenders) discussed their experiences as predominantly positive: they felt better understood and supported, learnt new things from peers and clinicians, and were better able to normalise diabetes self-care. Only in a few instances did young patients express (initial) reluctance to share clinical details or found peer comparison challenging; in these cases, internal dynamics required careful management by clinicians.

Group clinics provided the opportunity to discuss emotions and frustrations with others going through similar challenges. Young people found peers could understand and identify with their experiences, which made them feel less isolated. They felt better able to engage in open discussion as they gained encouragement from each other when they started to realise how all were struggling to follow clinical recommendations:

F1: How, I just want to ask generally, how are you guys, like those on type 1, how are you guys finding carb counting? How do you get round it, how do you start all up? F2: I’m not going to lie I haven’t been really carb counting. F1: OK I’m glad to [have asked], I mean it’s a bad thing but it’s like I’ve been struggling so much I’m just like I’ve given up with it totally. Are you the same like? F2: (indicates agreement) (Site A, exchange between female patients in Clinic 2)

Being able to explore emotional challenges of living with diabetes was repeatedly mentioned as a key aspect of positive experiences in group clinics, compared to individual appointments, where young people expressed reluctance to voice their difficulties:

The one-to-one is more personalised, scientific. […] Where [the group clinic] is more lifestyle based. It’s more about how to live with your diabetes, rather than just manage it […] With the doctor, I kind of want to just get it over and done with really quickly, and then just go. So I wouldn’t, I don’t try to ask as many questions or I just forget. (Interview 27, Patient 16)

One of the young people with type 2 diabetes did express feeling alienated initially, in a clinic where everyone else had type 1 diabetes, but then explained: ‘it was [a] very welcome [environment] so, feelings of being left out didn’t last too long to be honest’ (Interview 24, Patient 15)

Another participant suggested that they felt less comfortable with individual appointments because they perceived them as ‘professional’—which at their life stage seemed alienating, as they were unsure how to navigate the rules of engagement and match them with their own priorities.

Social and situated learning emerged through a combination of patient input and clinical advice (e.g. on alternating injection sites, ketone testing or avoiding hypos), carefully facilitated by the diabetes specialist nurses who ensured young people gained insight without feeling judged or criticised. Learning emerged both for those newly diagnosed and for those diagnosed at a younger age, who had been looked after by their families and were only just beginning to learn how to care for themselves independently. Clinicians were surprised that young people had not already acquired this learning through individual appointments on similar topics.

Patient participants talked about how group discussions with peers helped them think about their diabetes differently and normalise their experiences through getting to know how others approached their self-care. This even resulted in some feeling more confident and comfortable with their condition to the extent they started disclosing to their workplace and friends:

[…] within the workplace I would never tell people that I’ve got diabetes, and stuff like that. Now, the other day I was speaking to my friend about where I should be injecting, where I shouldn’t be injecting. Feel like now I’m a bit more confident and comfortable with it. (Interview 13, Patient 8)

There was, however, some reluctance to share clinical details considered private (e.g. glucose levels) or have test results displayed on the computer screen for discussion. Others were not always prepared to discuss self-care aspects they were struggling with or to manage a group discussion that might have led to sharing beyond what they were comfortable with, so chose to control their contributions. For those newly diagnosed, comparison with peers was not always motivating, especially when they were comparing themselves with others doing worse:

And so what I was thinking is that would it get to a stage where it’s going to be hard for me to manage my diabetes. Yeah, it definitely did freak me out a bit, yeah. (Interview 14, Patient 9)

Costs of group consultations and health care

The average staff costs for setting-up and delivering group consultations were similar across the two implementation sites (£572 for site A and £545 for site B) (Additional file 1: Tables 1a and 1b). The average cost of clinic per participant was marginally higher in site A (£158) compared to site B (£127), due to poorer attendance in the former (average number of participants was 3.7 for site A versus 4.5 for site B) (Additional file 1: Table 2). The study participants attended on average 3.6 out of 5.9 scheduled appointments per year, including consultations with a diabetes doctor, diabetes specialist nurse, dietician, and psychologist. The average annual cost of scheduled care was £723 per patient per year. The study participants had on average 3.9 unscheduled contacts per year including A&E visits, hospital admissions, and contacts with general practitioners and diabetes specialist nurses. The average annual cost of unscheduled care was £2566 per patient (Additional file 1: Table 3).

[ad_2]

Source link

Steven Adams, Anika Moa urge support for teen’s diabetes campaign

Diabetes News

[ad_1]

Basketball star Steven Adams and singer Anika Moa are backing a Tauranga teenager’s campaign after he petitioned the government to fund lifesaving equipment for New Zealanders with type 1 diabetes.

Posting a photo of his nephew Kepaleli, the NBA player urged people to sign the petition to fund lifesaving monitoring equipment.

The petition, set up by 16-year-old Toby Good, aims to secure Continuous Glucose Monitoring (CGM) technology for the 26,000 children and adults living with type 1 diabetes in Aotearoa.

READ MORE:
* Pharmac ‘procrastinating’ over funding glucose monitors, Diabetes NZ says
* Wellington teen with type 1 diabetes raises thousands for unfunded glucose monitor for children
* Difference between Type One diabetes and Type 2 diabetes explained

Adam’s nephew Kepaleli, the son of his Olympian sister Dame Valerie Adams, was diagnosed with type 1 diabetes in 2020. Adams has spoken about how the CGM device helped their family.

“When we came home, it felt like we had a newborn baby – that same sense of nervousness and paranoia,” he said. “We were up every hour pricking his finger, it was awful.

“A couple of months down the line, we discovered a device we could attach to Kepaleli, letting us get his blood glucose readings on our phones just so we’re not constantly causing him pain. We’re now close to two years in, and we’ve become more relaxed about Kepaleli’s condition.”

Singer Anika Moa also urged people to sign the petition after explaining how it had helped her battle the condition.

Steven Adam’s nephew Kepaleli was diagnosed with type 1 diabetes in 2020.

SUPPLIED/Stuff

Steven Adam’s nephew Kepaleli was diagnosed with type 1 diabetes in 2020.

“My life completely changed on the day I was diagnosed with type 1 diabetes,” said Moa. “My symptoms were so obvious but not to me, who didn’t even understand what kind of f****d up autoimmune disease I had.

“With the help of my CGM monitor/Dexcom 6 and the diabetes specialists, it has helped me wake up (most) days happy, healthy and feeling loads better than a year ago.

“So please, please, please – if you have time today, sign this petition to get CGM’s funded. It literally saves lives. I want all our kids in Aotearoa to be able to get these free.”

Toby Good, who has type 1 diabetes himself, said CGM devices saved lives by warning users when blood glucose levels were dangerously high or low.

“They reduce the burden on individuals, families, and the health system and improve overall health outcomes,” said Good.

Despite being funded in many countries, including Australia, Canada and the UK, Pharmac does not currently fund the monitor.

“Costs of the device make it unaffordable for many families,” said Good. “People care about this. I never asked for type 1 diabetes. The condition has no known cause or cure. What I do know is that the CGM has saved my life, several times.”

Anika Moa.

Nicky Claridge

Anika Moa.

Good said thousands of New Zealanders had already signed the petition.

”It’s great that Steven Adams, Val Adams and Anika Moa have backed our cause,” he said. “We can’t wait any longer. Lives are at risk. It’s not fair.”

Good’s mother, Lavina Good, said that while she was able to pay for the device for her son, many people were missing out.

”Pharmac just needs to read the comments on Toby’s petition,” she said. “They say it all. One mother said its insane she has to find $389.50 a month to give her son a chance.

“Many families just can’t do that. This is an incurable, life-threatening disease with reasonable outcomes only for those with resources. It is morally wrong.”

Diabetes New Zealand have previously said Pharmac needed to “stop procrastinating” over funding of the monitors.

Pharmac’s director of operations, Lisa Williams, said there were two CGMs on their options for investment list that it was considering funding.

“We are also reviewing our approach to the assessment of diabetes technologies, ensuring we are considering emerging evidence and applying this consistently across all currently open funding applications,” said Williams.

Pharmac director of operations Lisa Williams.

Supplied

Pharmac director of operations Lisa Williams.

“Unlike other countries, Pharmac works within a fixed budget, which means that we need to make difficult choices about which items to fund within the available budget.

“To achieve the best health outcomes, we have to prioritise our decisions. This prioritisation is dynamic, and we must take the time to consider various ways in which funding (or not funding) a medicine would impact New Zealanders.

“Because of this, we cannot provide a definitive timeframe for if or when medicines will be funded – something we know can be difficult to hear.”

In May 2022 the government announced a $191 million budget increase for Pharmac over 2022/23 and 2023/24 to spend on pharmaceuticals.

“We are currently working our way through our options for investment list, negotiating agreements with suppliers,” said Williams.

“So far this year (July 1, 2022 – June 30, 2023), Pharmac has funded 12 new treatments and widened access to 17 medicines, and we hope to fund many more treatments over the coming 12-to-24 months.”

[ad_2]

Source link

1 7 8 9 10 11